Cargando…
Chronic Myeloid Leukemia as a Secondary Malignancy Following Treatment of Diffuse Large B-Cell Lymphoma
Autores principales: | Demiriz, Itır Şirinoğlu, Tekgündüz, Emre, Bozdağ, Sinem Civriz, Altuntaş, Fevzi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996641/ https://www.ncbi.nlm.nih.gov/pubmed/24764737 http://dx.doi.org/10.4274/Tjh.2013.0180 |
Ejemplares similares
-
Diagnosis of Large Granular Lymphocytic Leukemia in a Patient Previously Treated for Acute Myeloblastic Leukemia
por: Bozdag, Sinem Civriz, et al.
Publicado: (2013) -
Finding the Optimal Conditioning Regimen for Relapsed/Refractory Lymphoma Patients Undergoing Autologous Hematopoietic Cell Transplantation: A Retrospective Comparison of BEAM and High-Dose ICE
por: Esbah, Onur, et al.
Publicado: (2016) -
What Is the Most Appropriate Source for Hematopoietic Stem Cell
Transplantation? Peripheral Stem Cell/Bone Marrow/Cord Blood
por: Sirinoglu Demiriz, Itır, et al.
Publicado: (2012) -
Primary Breast Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma Transformation to Diffuse Large B-cell Lymphoma: A Case Report
por: Arslan, Şerife Hülya, et al.
Publicado: (2012) -
Coexistence of Essential Thrombocythemia, Iron-Refractory Iron Deficiency Anemia and Renal Cell Carcinoma
por: Namdaroğlu, Sinem, et al.
Publicado: (2016)